An amyloidogenic determinant in n-terminal pro-brain natriuretic peptide (nt-probnp): Implications for cardiac amyloidoses
β Scribed by Vassiliki A. Iconomidou; Danae Pheida; Eftihia S. Hamodraka; Claude Antony; Andreas Hoenger; Stavros J. Hamodrakas
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2011
- Tongue
- English
- Weight
- 974 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0006-3525
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background In the early identification of cardiovascular risk, it is essential to establish a biological marker for cardiac complications that is comparable to albuminuria for nephropathy. We tested the hypothesis that __N__βterminal proβbrain natriuretic peptide (NTβproBNP) might b
## Background: Circulating plasma n-terminal pro-brain natriuretic peptide (nt-probnp) concentration facilitates emergency diagnosis of congestive heart failure (chf) in people. its utility to discriminate between dyspneic cats with chf vs. primary respiratory disease requires further assessment. o
## Background: N-terminal pro-brain natriuretic peptide (nt-probnp) is an important biomarker to indicate cardiac function, but its significance in cardiac surgery is still unclear. ## Objective: To explore clinical significance of serum nt-probnp and their dynamic characteristics in patients wit